Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar 23:8:75-81.
doi: 10.2147/HIV.S96883. eCollection 2016.

Magnitude of visceral leishmaniasis and poor treatment outcome among HIV patients: meta-analysis and systematic review

Mekuriaw Alemayehu  1 , Mamo Wubshet  1 , Nebiyu Mesfin  2
Affiliations

Magnitude of visceral leishmaniasis and poor treatment outcome among HIV patients: meta-analysis and systematic review

Mekuriaw Alemayehu et al. HIV AIDS (Auckl). .

Abstract

Background: Visceral leishmaniasis (VL) coinfection with HIV/AIDS most often results in unfavorable responses to treatment, frequent relapses, and premature deaths. Scarce data are available, regarding the magnitude and poor treatment outcomes of VL-HIV coinfection.

Objective: The main objective of this systematic review was to describe the pooled prevalence of VL and poor treatment outcome among HIV patients.

Review methods: Electronic databases mainly PubMed were searched. Databases, such as Google and Google scholar, were searched for gray literature. Articles were selected based on their inclusion criterion, whether they included HIV-positive individuals with VL diagnosis. STATA 11 software was used to conduct a meta-analysis of pooled prevalence of VL-HIV coinfection.

Results: Fifteen of the 150 articles fulfilled the inclusion criteria. A majority of the study participants were males between 25 years and 41 years of age. The pooled prevalence of VL-HIV coinfection is 5.2% with 95% confidence interval of (2.45-10.99). Two studies demonstrated the impact of antiretroviral treatment on reduction in relapse rate compared with patients who did not start antiretroviral treatment. One study showed that the higher the baseline CD4+ cell count (>100 cells/mL) the lower the relapse rate. Former VL episodes were identified as risk factors for relapse in two articles. In one of the articles, an earlier bout of VL remains significant in the model adjusted to other variables.

Conclusion: The pooled prevalence of VL in HIV-infected patients is low and an earlier bout of VL and CD4+ count <100 cells/mL at the time of primary VL diagnosis are factors that predict poor treatment outcome.

Keywords: HIV coinfection; magnitude; visceral leishmaniasis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Terms used in PubMed search. Abbreviation: VL, visceral leishmaniasis.
Figure 2
Figure 2
Study selection process. Abbreviation: VL, visceral leishmaniasis.
Figure 3
Figure 3
Meta-analysis of pooled prevalence of VL-HIV coinfection. Note: Weights are from random effects analysis. Abbreviation: VL, visceral leishmaniasis; ES, estimate.
See this image and copyright information in PMC

References

    1. Desjeux P. The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg. 2001;95:239–243. - PubMed
    1. Kubar J, Marty P, Lelievre A, et al. Visceral leishmaniosis in HIV positive patients: primary infection, reactivation and latent infection: impact of the CD4+ T-lymphocyte counts. AIDS. 1998;12:2147–2153. - PubMed
    1. Paredes R, Munoz J, Diaz I, Domingo P, Gurgui M, Clotet B. Leishmaniasis in HIV infection. J Postgrad Med. 2003;49:39–49. - PubMed
    1. Alvar J, Canavate C, Gutierrez-Solar B, et al. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev. 1997;10:298–319. - PMC - PubMed
    1. Wolday D, Akuffo H, Demissie A, Britton S. Role of Leishmania donovani and its lipophosphoglycan in CD4+ T-cell activation-induced human immunodeficiency virus replication. Infect Immun. 1999;67:5258–5264. - PMC - PubMed